The DOI matches its Crossref record.
The Topographical and Neuroanatomical Distribution of Neurofibrillary Tangles and Neuritic Plaques in the Cerebral Cortex of Patients with Alzheimer's Disease
Abstract
The distribution of neurofibrillary tangles (NFTs) and neuritic plaques (NPs) was mapped in 39 cortical areas of 11 brains of patients with Alzheimer's disease (AD). Whole hemisphere blocks were embedded in polyethylene glycol (Carbowax), sectioned coronally, and stained with thioflavin S and thionin. The densities of NFTs and NPs were assessed using a numerical rating scale for each area. Scores were grouped by type of cortex and by lobe for statistical analysis. Highly significant differences were obtained. For example, limbic periallocortex and allocortex had more NFTs than any other type of cortex. In descending order, the density of NFTs was as follows: periallocortex (area 28) greater than allocortex (subiculum/CA1 zones of hippocampal formation, area 51) greater than corticoid areas (accessory basal nucleus of amygdala, nucleus basalis of Meynert) greater than proisocortex (areas 11, 12, 24, 23, anterior insula, 38, 35) greater than nonprimary association cortex (32, 46, superior temporal sulcus, 40, 39, posterior parahippocampal cortex, 37, 36) greater than primary sensory association cortex (7, 18, 19, 22, 21, 20) greater than agranular cortex (44-5, 8, 6, 4) greater than primary sensory cortex (41-2, 3-1-2, 17). The laminar distribution of NFTs tended to be selective, involving primarily layers III and V of association areas and layers II and IV of limbic periallocortex. There were far more NFTs in both limbic and temporal lobes than in frontal, parietal, and occipital lobes. In general, NPs were more evenly distributed throughout the cortex, with the exceptions of limbic periallocortex and allocortex, which had notably fewer NPs than other cortical areas. Temporal and occipital lobes had the highest NP densities, limbic and frontal lobes had the lowest, and parietal lobe was intermediate. No significant left-right hemispheric differences for NFT or NP densities were found across the population, and there was no relationship between duration of illness and densities of NFTs or NPs. The regional and laminar distribution of NFTs (and, to a lesser degree, that of NPs) suggests a consistent pattern of vulnerability within the cerebral cortices that seems correlated to the hierarchies of cortico-cortical connections. The higher-order association cortices, especially those in the anterior and ventromedial sectors of temporal lobe, are the most vulnerable, while other cortices appear less vulnerable to a degree commensurate with their connectional "distance" (i.e., synapses removed) from the limbic areas.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The EC is affected severely in Alzheimer disease (AD), likely contributing to memory impairment.”
From Profound Loss of Layer II Entorhinal Cortex Neurons Occurs in Very Mild Alzheimer’s Disease (1996) · cites this paper as Arnold et al., 1991
In the citing paper
“The EC was chosen because it is highly selectively vulnerable in AD (Hyman et al., 1984(Hyman et al., , 1986;;Arnold et al., 1991;Braak and Braak, 1991;Price et al., 1991;Arriagada et al., 1992a;Fukutani et al., 1995;Solodkin and Van Hoesen, 1996).”
From Profound Loss of Layer II Entorhinal Cortex Neurons Occurs in Very Mild Alzheimer’s Disease (1996) · cites this paper as Arnold et al., 1991
In the citing paper
“The midfrontal gyrus cortex (corresponding predominantly to Brodmann area 46) was chosen for semi-quantitative image analyses of AD pathology, cellular and synaptic markers because of its important role in complex cognition and its common neuropathological involvement in the spectrum of AD (Arnold, et al., 1991).”
From Cellular, synaptic, and biochemical features of resilient cognition in Alzheimer’s disease (2013) · cites this paper as Arnold, et al., 1991
In the citing paper
“as this region is the first area of the brain involved by the neurofibrillary pathology of AD(4, 5).”
From Rates of hippocampal atrophy correlate with change in clinical status in aging and AD (2000) · cites this paper as [5]
In the citing paper
“We consider it to be an important clue that most brains from elderly human subjects show abnormalities that fall somewhere along particular continua of pathologic severity (60, 96-100).”
From Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature (2012) · cites this paper as [100]
In the citing paper
“In the early stages of Alzheimer’s disease (AD), the most common form of age-related dementia, clinical symptoms (such as memory loss) are caused by the selective degeneration of principal neurons of the entorhinal cortex layer II (ECII), followed by CA1 pyramidal cells in the hippocampus, and pyramidal neurons in neocortical association areas.”
From Selective Neuronal Vulnerability in Alzheimer’s Disease: A Network-Based Analysis (2020) · cites this paper as Arnold et al., 1991
In the citing paper
“In contrast, other brain regions, such as the primary sensory cortices, are relatively resistant to degeneration until later stages of the disease (Arnold et al., 1991; Bussière et al., 2003; Fukutani et al., 2000; Gómez-Isla et al., 1996; Hof and Morrison, 1990; Hyman et al., 1984; Morrison and Hof, 1997; West et al., 1994).”
From Selective Neuronal Vulnerability in Alzheimer’s Disease: A Network-Based Analysis (2020) · cites this paper as Arnold et al., 1991
Citations
Cites
Still being checked.
Cited by
Sorted by citations
Items 101–200 of 1,002
Greeve, I., Hermans‐Borgmeyer, I., Brellinger, C., Kasper, D., Gómez‐Isla, T., Behl, C., Levkau, B., & Nitsch, R. M. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-19-07345.2000 · Cited by 300
Neural Systems for Reading Aloud: A Multiparametric Approach
Graves, W. W., Desai, R. H., Humphries, C., Seidenberg, M. S., & Binder, J. R. (2009) · Cerebral Cortex · doi:10.1093/cercor/bhp245 · Cited by 310
Dickson, T. C., & Vickers, J. C. (2001) · Neuroscience · doi:10.1016/s0306-4522(01)00169-5 · Cited by 294
Chen, X., & Mobley, W. C. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00659 · Cited by 302
Bouras, C., Hof, P. R., Giannakopoulos, P., Michel, J.-P., & Morrison, J. H. (1994) · Cerebral Cortex · doi:10.1093/cercor/4.2.138 · Cited by 280
Neuropsychological and neuroimaging changes in preclinical Alzheimer's disease
Twamley, E. W., Ropacki, S., & Bondi, M. W. (2006) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617706060863 · Cited by 291
Götz, J., Streffer, J. R., David, D. C., Schild, A., Hoerndli, F. J., Pennanen, L., Kurosinski, P., & Chen, F. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001508 · Cited by 284
Tau PET in Alzheimer disease and mild cognitive impairment
Cho, H., Choi, J. Y., Hwang, M. S., Lee, J., Kim, Y. J., Lee, H., Lyoo, C. H., Ryu, Y. H., & Lee, M. S. (2016) · Neurology · doi:10.1212/wnl.0000000000002892 · Cited by 274
Buxbaum, J. D., Thinakaran, G., Koliatsos, V. E., O’Callahan, J., Slunt, H. H., Price, D. L., & Sisodia, S. S. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-23-09629.1998 · Cited by 266
Non-invasive assessment of Alzheimer’s disease neurofibrillary pathology using 18F-THK5105 PET
Okamura, N., Furumoto, S., Fodero‐Tavoletti, M. T., Mulligan, R. S., Harada, R., Yates, P. A., Pejoska, S., Kudo, Y., Masters, C. L., Yanai, K., et al. (2014) · Brain · doi:10.1093/brain/awu064 · Cited by 273
Cortical variability and asymmetry in normal aging and Alzheimer's disease
Thompson, P. M. (1998) · Cerebral Cortex · doi:10.1093/cercor/8.6.492 · Cited by 264
Memory encoding in Alzheimer's disease: an fMRI study of explicit and implicit memory
Golby, A. J. (2005) · Brain · doi:10.1093/brain/awh400 · Cited by 260
Ng, S., Villemagne, V. L., Berlangieri, S. U., Lee, S.-T., Cherk, M. H., Gong, S., Ackermann, U., Saunder, T., Tochon‐Danguy, H., Jones, G. R., et al. (2007) · Journal of Nuclear Medicine · doi:10.2967/jnumed.106.037762 · Cited by 258
Rabinovici, G. D., Seeley, W. W., Kim, E. J., Gorno‐Tempini, M. L., Rascovsky, K., Pagliaro, T. A., Allison, S. C., Halabi, C., Kramer, J. H., Johnson, J. K., et al. (2007) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317507308779 · Cited by 264
Early DAT is distinguished from aging by high-dimensional mapping of the hippocampus
Csernansky, J. G., Wang, L., Joshi, S. C., Miller, J. P., Gado, M., Kido, D. K., McKeel, D. W., Morris, J. C., & Miller, M. I. (2000) · Neurology · doi:10.1212/wnl.55.11.1636 · Cited by 259
Zhang, Z., Liu, Y., Jiang, T., Zhou, B., An, N., Dai, H., Wang, P., Niu, Y., Wang, L., & Zhang, X. (2012) · NeuroImage · doi:10.1016/j.neuroimage.2011.08.049 · Cited by 255
Scarmeas, N., Zarahn, E., Anderson, K. E., Habeck, C. G., Hilton, J., Flynn, J., Marder, K. S., Bell, K. L., Sackeim, H. A., Van Heertum, R. L., et al. (2003) · Archives of Neurology · doi:10.1001/archneur.60.3.359 · Cited by 254
3D comparison of hippocampal atrophy in amnestic mild cognitive impairment and Alzheimer's disease
Apostolova, L. G., Dinov, I. D., Dutton, R. A., Hayashi, K. M., Toga, A. W., Cummings, J. L., & Thompson, P. M. (2006) · Brain · doi:10.1093/brain/awl274 · Cited by 251
Thompson, P. M., Hayashi, K. M., Dutton, R. A., Chiang, M., Leow, A., Sowell, E. R., de Zubicaray, G. I., Becker, J. T., López, O. L., Aizenstein, H. J., et al. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1379.017 · Cited by 259
Mitchell, T. W., Mufson, E. J., Schneider, J. A., Cochran, E. J., Nissanov, J., Han, L., Bienias, J. L., Lee, V. M. ‐., Trojanowski, J. Q., Bennett, D. A., et al. (2002) · Annals of Neurology · doi:10.1002/ana.10086 · Cited by 251
Self-citationWolk, D. A., Dickerson, B. C., Initiative, T. A. D. N., Weiner, M., Aiello, M., Aisen, P., Albert, M. S., Alexander, G., Anderson, H. S., Anderson, K., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1001412107 · Cited by 248
Self-citationHof, P. R., Vogt, B. A., Bouras, C., & Morrison, J. H. (1997) · Vision Research · doi:10.1016/s0042-6989(96)00240-4 · Cited by 246
Morrison, J. H., & Hof, P. R. (2002) · Progress in brain research · doi:10.1016/s0079-6123(02)36039-4 · Cited by 241
Bakkour, A., Morris, J. C., Wolk, D. A., & Dickerson, B. C. (2013) · NeuroImage · doi:10.1016/j.neuroimage.2013.02.059 · Cited by 251
Kudo, Y., Okamura, N., Furumoto, S., Tashiro, M., Furukawa, K., Maruyama, M., Itoh, M., Iwata, R., Yanai, K., & Arai, H. (2007) · Journal of Nuclear Medicine · doi:10.2967/jnumed.106.037556 · Cited by 240
García‐Cabezas, M. Á., Zikopoulos, B., & Barbas, H. (2019) · Brain Structure and Function · doi:10.1007/s00429-019-01841-9 · Cited by 237
The Development of Amyloid β Protein Deposits in the Aged Brain
Thal, D. R., Capetillo-Zarate, E., Del Tredici, K., & Braak, H. (2006) · Science of Aging Knowledge Environment · doi:10.1126/sageke.2006.6.re1 · Cited by 234
Gabrieli, J. D. E., Corkin, S., Mickel, S. F., & Growdon, J. H. (1993) · Behavioral Neuroscience · doi:10.1037//0735-7044.107.6.899 · Cited by 234
Hof, P. R. (1995) · Archives of Neurology · doi:10.1001/archneur.1995.00540280065020 · Cited by 242
Delacourte, A., Sergeant, N., Wattez, A., Gauvreau, D., & Robitaille, Y. (1998) · Annals of Neurology · doi:10.1002/ana.410430209 · Cited by 235
Perez, S. E., Lumayag, S., Kovacs, B., Mufson, E. J., & Xu, S. (2009) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.08-2384 · Cited by 236
3D in vitro modeling of the central nervous system
Hopkins, A. M., DeSimone, E. K., Chwalek, K., & Kaplan, D. L. (2014) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2014.11.003 · Cited by 234
Cognitive Test Performance in Detecting, Staging, and Tracking Alzheimer's Disease
Locascio, J. J., Growdon, J. H., & Corkin, S. (1995) · Archives of Neurology · doi:10.1001/archneur.1995.00540350081020 · Cited by 228
Serrano-Pozo, A., Muzikansky, A., Gómez-Isla, T., Growdon, J. H., Betensky, R. A., Frosch, M. P., & Hyman, B. T. (2013) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3182933788 · Cited by 226
Self-citationAmyloid Imaging in Aging and Dementia: Testing the Amyloid HypothesisIn Vivo
Rabinovici, G. D., & Jagust, W. J. (2009) · Behavioural Neurology · doi:10.1155/2009/609839 · Cited by 234
Clinical subtypes of Alzheimer’s disease
Petersen, R. C. (1998) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000051199 · Cited by 223
Takahashi, S., Yonezawa, H., Takahashi, J., Kudo, M., Inoue, T., & Tohgi, H. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(02)00914-x · Cited by 225
Motor cortex excitability in Alzheimer's disease: A transcranial magnetic stimulation study
Ferreri, F., Pauri, F., Pasqualetti, P., Fini, R., Forno, G. D., & Rossini, P. M. (2002) · Annals of Neurology · doi:10.1002/ana.10416 · Cited by 223
Tau alteration and neuronal degeneration in tauopathies: mechanisms and models
Brandt, R., Hundelt, M., & Shahani, N. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2004.06.018 · Cited by 235
MRI and CSF studies in the early diagnosis of Alzheimer's disease
de Leon, M. J., DeSanti, S., Zinkowski, R. P., Mehta, P. D., Praticò, D., Segal, S., Clark, C. M., Kerkman, D. J., DeBernardis, J. F., Li, J., et al. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01381.x · Cited by 226
The Role of Copper Homeostasis in Brain Disease
An, Y., Li, S., Huang, X., Chen, X., Shan, H., & Zhang, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232213850 · Cited by 229
Higher Rates of Decline for Women and Apolipoprotein E ε4 Carriers
Holland, D., Desikan, R. S., Dale, A. M., & McEvoy, L. K. (2013) · American Journal of Neuroradiology · doi:10.3174/ajnr.a3601 · Cited by 219
The Relationship between Obstructive Sleep Apnea and Alzheimer’s Disease
Andrade, A. G., Bubu, O. M., Varga, A. W., & Osorio, R. S. (2018) · Journal of Alzheimer's Disease · doi:10.3233/jad-179936 · Cited by 216
Olfactory epithelium amyloid‐β and paired helical filament‐tau pathology in Alzheimer disease
Arnold, S. E., Lee, E. B., Moberg, P. J., Stutzbach, L., Kazi, H., Han, L., Lee, V. M. ‐., & Trojanowski, J. Q. (2009) · Annals of Neurology · doi:10.1002/ana.21910 · Cited by 215
Self-citationInsulin Resistance as a Link between Amyloid-Beta and Tau Pathologies in Alzheimer’s Disease
Mullins, R. J., Diehl, T. C., Chia, C. W., & Kapogiannis, D. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00118 · Cited by 227
Mullane, K., & Williams, M. J. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.11.014 · Cited by 219
Intact delay-eyeblink classical conditioning in amnesia.
Gabrieli, J. D. E., McGlinchey, R. E., Carrillo, M. C., Gluck, M. A., Cermak, L. S., & Disterhoft, J. F. (1995) · Behavioral Neuroscience · doi:10.1037/0735-7044.109.5.819 · Cited by 212
Hyman, B. T., West, H. L., Rebeck, G. W., Buldyrev, S. V., Mantegna, R. N., Ukleja, M., Havlin, S., & Stanley, H. E. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.8.3586 · Cited by 212
Self-citationCounts, S., Nadeem, M., Lad, S. P., Wuu, J., & Mufson, E. J. (2006) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-200606000-00007 · Cited by 212
VAN HOESEN, G. W., AUGUSTINACK, J. C., DIERKING, J., REDMAN, S. J., & THANGAVEL, R. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06731.x · Cited by 211
Krasuski, J., Alexander, G. E., Horwitz, B., Daly, E., Murphy, D., Rapoport, S. I., & Schapiro, M. B. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(97)00013-9 · Cited by 210
Lehmann, M., Crutch, S. J., Ridgway, G. R., Ridha, B. H., Barnes, J., Warrington, E. K., Rossor, M. N., & Fox, N. C. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.08.017 · Cited by 208
Lund, J. S., & Lewis, D. A. (1993) · The Journal of Comparative Neurology · doi:10.1002/cne.903280209 · Cited by 208
Regional brain stiffness changes across the Alzheimer's disease spectrum
Murphy, M. C., Jones, D. T., Jack, C. R., Glaser, K. J., Senjem, M. L., Manduca, A., Felmlee, J. P., Carter, R. E., Ehman, R. L., & Huston, J. (2015) · NeuroImage Clinical · doi:10.1016/j.nicl.2015.12.007 · Cited by 215
Ullman, M. T., Pancheva, R., Love, T. E., Yee, E., Swinney, D., & Hickok, G. S. (2004) · Brain and Language · doi:10.1016/j.bandl.2004.10.001 · Cited by 211
Fractionating verbal episodic memory in Alzheimer's disease
Wolk, D. A., & Dickerson, B. C. (2010) · NeuroImage · doi:10.1016/j.neuroimage.2010.09.005 · Cited by 211
Cholinergic Neuronal and Axonal Abnormalities Are Present Early in Aging and in Alzheimer Disease
Geula, C., Nagykery, N. G., Nicholas, A., & Wu, C. (2008) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31816a1df3 · Cited by 204
Sanchez, J. S., Becker, J. A., Jacobs, H. I. L., Hanseeuw, B. J., Jiang, S., Schultz, A. P., Properzi, M. J., Katz, S. R., Beiser, A., Satizabal, C. L., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abc0655 · Cited by 200
Age and amyloid effects on human central nervous system amyloid‐beta kinetics
Patterson, B. W., Elbert, D. L., Mawuenyega, K. G., Kasten, T., Ovod, V., Ma, S., Xiong, C., Chott, R., Yarasheski, K., Sigurdson, W., et al. (2015) · Annals of Neurology · doi:10.1002/ana.24454 · Cited by 200
Arnold, S. E., Trojanowski, J. Q., Gur, R. E., Blackwell, P., Han, L., & Choi, C. (1998) · Archives of General Psychiatry · doi:10.1001/archpsyc.55.3.225 · Cited by 200
Self-citationImaging and CSF Studies in the Preclinical Diagnosis of Alzheimer's Disease
de Leon, M. J., Mosconi, L., Blennow, K., DeSanti, S., Zinkowski, R. P., Mehta, P. D., Praticò, D., Tsui, W., Louis, L. A. S., Sobanska, L., et al. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1379.012 · Cited by 200
Dickerson, B. C., & Sperling, R. A. (2009) · Behavioural Neurology · doi:10.1155/2009/610392 · Cited by 204
Brückner, G., Hausen, D., Härtig, W., Drlicek, M., Arendt, T., & Brauer, K. (1999) · Neuroscience · doi:10.1016/s0306-4522(99)00071-8 · Cited by 196
Longitudinal Changes in Cerebral Blood Flow in the Older Hypertensive Brain
Beason‐Held, L. L., Moghekar, A., Zonderman, A. B., Kraut, M. A., & Resnick, S. M. (2007) · Stroke · doi:10.1161/strokeaha.106.477109 · Cited by 195
Neurofibrillary Tangles and Alzheimer’s Disease
Brion, J. (1998) · European Neurology · doi:10.1159/000007969 · Cited by 208
Gray matter asymmetries in aging and neurodegeneration: a review and meta-analysis.
Minkova, L., Habich, A., Peter, J., Kaller, C. P., Eickhoff, S. B., & Klöppel, S. (2017) · Human Brain Mapping · doi:10.1002/hbm.23772 · Cited by 194
Ghoshal, N. (2002) · Experimental Neurology · doi:10.1006/exnr.2002.8014 · Cited by 192
Substantial Archaeocortical Atrophy and Neuronal Loss in Multiple Sclerosis
Papadopoulos, D., Dukes, S., Patel, R., Nicholas, R., Vora, A., & Reynolds, R. (2009) · Brain Pathology · doi:10.1111/j.1750-3639.2008.00177.x · Cited by 192
Ding, S., Van Hoesen, G. W., Cassell, M. D., & Poremba, A. (2009) · Journal of Comparative Neurology · doi:10.1002/cne.22053 · Cited by 191
Neurogenetic contributions to amyloid beta and tau spreading in the human cortex
Sepulcre, J., Grothe, M. J., Uquillas, F. D., Ortiz-Terán, L., Diez, I. P., Yang, H., Jacobs, H. I. L., Hanseeuw, B. J., Li, Q., Fakhri, G. E., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0206-4 · Cited by 195
Alzheimer's Disease: Redox Dysregulation As a Common Denominator for Diverse Pathogenic Mechanisms
Rommy von Bernhardi, M., & Eugenín, J. L. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2011.4082 · Cited by 193
Gabrieli, J. D. E., Stebbins, G. T., Singh, J., Willingham, D. B., & al, E. (1997) · Neuropsychology · doi:10.1037/0894-4105.11.2.272 · Cited by 188
Arendt, T. (2003) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2003.09.007 · Cited by 189
Quiroz, Y. T., Sperling, R. A., Norton, D. J., Baena, A., Arboleda-Velasquez, J. F., Cosio, D., Schultz, A., Lapoint, M., Guzman-Velez, E., Miller, J. B., et al. (2018) · JAMA Neurology · doi:10.1001/jamaneurol.2017.4907 · Cited by 186
Alzheimer’s Disease: The Link Between Amyloid-β and Neurovascular Dysfunction
Solis, E., Hascup, K. N., & Hascup, E. R. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200473 · Cited by 192
Bussière, T., Giannakopoulos, P., Bouras, C., Perl, D. P., Morrison, J. H., & Hof, P. R. (2003) · Journal of Comparative Neurology · doi:10.1002/cne.10760 · Cited by 185
Jack, C. R., Petersen, R. C., Xu, Y. C., O’Brien, P. C., Waring, S. C., Tangalos, E. G., Smith, G. E., Ivnik, R. J., Thibodeau, S. N., & Kokmen, E. (1998) · Annals of Neurology · doi:10.1002/ana.410430307 · Cited by 187
Geula, C. (1998) · Neurology · doi:10.1212/wnl.51.1_suppl_1.s18 · Cited by 184
Gordon, B. A., Friedrichsen, K., Brier, M., Blazey, T., Su, Y., Christensen, J., Aldea, P., McConathy, J., Holtzman, D. M., Cairns, N. J., et al. (2016) · Brain · doi:10.1093/brain/aww139 · Cited by 184
Golob, E. J., Irimajiri, R., & Starr, A. (2007) · Brain · doi:10.1093/brain/awl375 · Cited by 183
Doré, V., Villemagne, V. L., Bourgeat, P., Fripp, J., Acosta, O., Chételat, G., Zhou, L., Martins, R. N., Ellis, K. A., Masters, C. L., et al. (2013) · JAMA Neurology · doi:10.1001/jamaneurol.2013.1062 · Cited by 190
Braak, H., & Braak, E. (1994) · Neurobiology of Aging · doi:10.1016/0197-4580(94)90032-9 · Cited by 181
Ohnishi, T., Matsuda, H., Tabira, T., Asada, T., & Uno, M. (2001) · PubMed Central · Cited by 181
Selective Neuronal Vulnerability in Alzheimer’s Disease: A Network-Based Analysis
Roussarie, J.-P., Yao, V., Rodriguez-Rodriguez, P., Oughtred, R., Rust, J., Plautz, Z., Kasturia, S., Albornoz, C., Wang, W., Schmidt, E. F., et al. (2020) · Neuron · doi:10.1016/j.neuron.2020.06.010 · Cited by 180
Increased Cerebral Metabolism After 1 Year of Deep Brain Stimulation in Alzheimer Disease
Smith, G. S., Laxton, A. W., Tang‐Wai, D. F., McAndrews, M. P., Diaconescu, A. O., Workman, C. I., & Lozano, A. M. (2012) · Archives of Neurology · doi:10.1001/archneurol.2012.590 · Cited by 180
The basolateral amygdala γ‐aminobutyric acidergic system in health and disease
Prager, E. M., Bergstrom, H. C., Wynn, G. H., & Braga, M. F. M. (2015) · Journal of Neuroscience Research · doi:10.1002/jnr.23690 · Cited by 192
Transgenic mouse models of Alzheimer's disease
Janus, C., & Westaway, D. A. (2001) · Physiology & Behavior · doi:10.1016/s0031-9384(01)00524-8 · Cited by 181
Development of Positron Emission Tomography β-Amyloid Plaque Imaging Agents
Mathis, C. A., Mason, N. S., Lopresti, B. J., & Klunk, W. E. (2012) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2012.07.001 · Cited by 181
Poor and protracted myelination as a contributory factor to neurodegenerative disorders
Braak, H., & Tredici, K. D. (2003) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.04.001 · Cited by 179
The Putative Visual Word Form Area Is Functionally Connected to the Dorsal Attention Network
Vogel, A. C., Miezin, F. M., Petersen, S. E., & Schlaggar, B. L. (2011) · Cerebral Cortex · doi:10.1093/cercor/bhr100 · Cited by 175
Dementia of the Alzheimer Type
Jalbert, J. J., Daiello, L. A., & Lapane, K. L. (2008) · Epidemiologic Reviews · doi:10.1093/epirev/mxn008 · Cited by 181
In Vivo Tau, Amyloid, and Gray Matter Profiles in the Aging Brain
Sepulcre, J., Schultz, A. P., Sabuncu, M. R., Gómez‐Isla, T., Chhatwal, J. P., Becker, A., Sperling, R. A., & Johnson, K. A. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.0639-16.2016 · Cited by 182
Autoradiography validation of novel tau PET tracer [F-18]-MK-6240 on human postmortem brain tissue
Agüero, C., Dhaynaut, M., Normandin, M. D., Amaral, A. C. S., Guehl, N. J., Neelamegam, R., Marquié, M., Johnson, K. A., Fakhri, G. E., Frosch, M. P., et al. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0686-6 · Cited by 177
Giannakopoulos, P., Hof, P. R., Michel, J., Guimón, J., & Bouras, C. (1997) · Brain Research Reviews · doi:10.1016/s0165-0173(97)00023-4 · Cited by 174
McDonald, A. J., & Mott, D. D. (2016) · Journal of Neuroscience Research · doi:10.1002/jnr.23709 · Cited by 189
Iglesias, J. E., Leemput, K. V., Augustinack, J. C., Insausti, R., Fischl, B. R., & Reuter, M. (2016) · NeuroImage · doi:10.1016/j.neuroimage.2016.07.020 · Cited by 170
Vallet, P. G., Guntern, R., Hof, P. R., Golaz, J., Delacourte, A., Robakis, N. K. R. K., & Bouras, C. (1992) · Acta Neuropathologica · doi:10.1007/bf00308476 · Cited by 170
Tapia‐Rojas, C., Aránguiz, F. C., Varela‐Nallar, L., & Inestrosa, N. C. (2015) · Brain Pathology · doi:10.1111/bpa.12255 · Cited by 176
Gabrieli, J. D. E., Keane, M. M., Stanger, B. Z., Kjelgaard, M., Corkin, S., & Growdon, J. H. (1994) · Cortex · doi:10.1016/s0010-9452(13)80325-5 · Cited by 167
Visual Association Pathology in Preclinical Alzheimer Disease
McKee, A. C., Au, R., Cabral, H., Kowall, N. W., Seshadri, S. S., Kubilus, C. A., Drake, J., & Wolf, P. A. (2006) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-200606000-00010 · Cited by 169
Metadata
- Authors
- Arnold, S. E., Hyman, B. T., Flory, J., Damasio, A. R., & Van Hoesen, G. W.
- Affiliations
- University of Iowa (US)
- Venue
- Cerebral Cortex
- Publisher
- Oxford University Press (OUP)
- Published
- 1991-01-01
- Volume
- 1
- Issue
- 1
- Pages
- 103-116
- ISSN
- 1047-3211 (ISSN-L)
- 1460-2199
- OpenAlex
- W2029923284
- Cited by
- 1,380
- References
- 0
- Citations by year
- 2026: 15 · 2025: 32 · 2024: 32 · 2023: 34 · 2022: 31 · 2021: 45 · 2020: 36 · 2019: 41 · 2018: 47 · 2017: 43 · 2016: 42 · 2015: 40 · 2014: 42 · 2013: 54 · 2012: 42
- FWCI
- 19.40
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Cerebral Cortex (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Public Health Service (P019632)
- National Institute on Aging (AG-08487)
- National Institute of Neurological Disorders and Stroke (R01NS014944, NS-14944)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Alzheimer's disease, neurofibrillary tangles, neuritic plaques, cortical topography, neuroanatomy, allocortex, temporal lobe, occipital lobe, frontal lobe, parietal lobe, laminar distribution, thioflavin S, thionin, amygdala, nucleus basalis of Meynert
- MeSH terms
- Aged, Alzheimer Disease, Brain Mapping, Cerebral Cortex, Female, Histocytochemistry, Humans, Male, Middle Aged, Neurites, Tissue Embedding, Neurofibrillary Tangles
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
